SYS-CON MEDIA Authors: Carmen Gonzalez, Sean Houghton, Glenn Rossman, Ignacio M. Llorente, Xenia von Wedel

News Feed Item

Serenus Biotherapeutics Strengthens Leadership With Appointments to Board and Management

Company Adds Team Members With Extensive Knowledge of Sub-Saharan African Markets and Global Biopharmaceutical Industry

SAN FRANCISCO, CA and JOHANNESBURG, SOUTH AFRICA -- (Marketwired) -- 07/24/14 -- Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company bridging the divide between the world's leading pharmaceutical markets and the growing demand for access to innovative therapies in the emerging nations of Sub-Saharan Africa, today announced appointments to its board of directors and senior management team.

The company named to its board of directors Sbu Luthuli, former Chairman of Cipla Medpro; Dr. Nigel Fleming, founder and former Chairman of Athena Diagnostics; and Kazuhiro Umeda, former President of JAIC Singapore, Indonesia, and Thailand.

In addition, the company made appointments to its executive management team. It named Moosa Areff, who most recently served as CEO of Ranbaxy South Africa's Sonke Pharmaceuticals subsidiary, as its Chief Operating Officer. It also named Andrew de Pão, who served as Head of Marketing of the Prescription Division at Cipla South Africa, as its Chief Business Officer; and Nahum Johnson, former Business Unit Manager - State Institutional and Government at Cipla Medpro, as Director State and Institutional Business.

"We are pleased to have attracted a distinguished group of board members to guide us as we begin to implement our plans, enter into new partnerships, and grow our company," says Dr. Menghis Bairu, founder, Chairman, and CEO of Serenus Biotherapeutics. "The additions we have made to our executive team give us the people on the ground with intimate knowledge of the Sub-Saharan African landscape needed to execute on our strategy."

Mr. Luthuli noted that the appointments come as the Sub-Saharan African market is experiencing rapid economic development, the emergence of a burgeoning middle class, and a marked shift in disease profiles.

"The Sub-Saharan African pharmaceutical market is growing rapidly as lifestyle changes are driving a shift in disease burden from infectious to chronic diseases. Nevertheless, access to needed innovative therapeutics is still limited today," says Mr. Luthuli. "Serenus offers an African access platform that uniquely positions it to serve as a partner of choice for biopharmaceutical companies with innovative therapies in developed markets that appreciate the opportunities in the emerging markets of Sub-Saharan Africa, but may not have the expertise or networks needed to address the complexity of doing business in the region."

Below are bios of the Serenus Biotherapeutics appointees announced today.

Sbu Luthuli
Member of the Board of Directors
Mr. Luthuli is the CEO and Principal Officer of the Eskom Pension and Provident Fund, one of the largest self-administered pension funds in South Africa with assets under management in excess of $10.4 billion (R110 billion). Prior to this, he served as CEO of Ithala Bank Limited, where he transformed and grew the bank through the launch of new products and the introduction of electronic banking. He is a director at Telkom SA Limited and also serves as the Vice Chairman of Batseta, an industry organization representing pension fund trustees and principal officers. He was involved with Cipla Medpro (formerly Enaleni Pharmaceuticals Limited) for ten years and served as Chairman of the Board of Directors until its sale to Cipla India in 2013.

Dr. Nigel Fleming
Member of the Board of Directors
Dr. Fleming is founder and Chairman of G2B Pharma Inc., which is reformulating off-patent drugs to significantly improve their safety or efficacy. He founded and served as Chairman of Athena Diagnostics, a leading provider of advanced neurodiagnostic tests, used for neuromuscular and metabolic diseases. Dr. Fleming has served on various boards, including Exemplar, Impax Labs, Genmedica Therapeutics, A-Cube, Minoryx Therapeutics (as Chairman), and the Institute for OneWorld Health. He has also served as a Lecturer at Harvard Medical School. He earned his Ph.D. in Clinical Biochemistry from Cambridge University, and completed a post-doctoral fellowship at Boston University Medical School.

Kazuhiro Umeda
Member of the Board of Directors
Mr. Kazuhiro in 2005 joined Japan Asia Investment Co. Ltd., one of Japan's largest Venture Capital Firms. He served as Head of the CEO's Office, as well as President, heading up the Japan Asia Investment Company's Singapore, Indonesia, and Thailand office. He also founded Apricot, a natural food and drink company as a vehicle for commonly used pharmaceuticals, a revolutionary approach for pharmaceutical dosing. His early career included sales promotion for Daiichi Pharmaceuticals Group of Japan. He earned a master's and bachelor's degree in life sciences from the Tokyo University of Pharmacy and Life Sciences.

Moosa Areff
Chief Operating Officer
Mr. Areff comes to Serenus with 18 years of experience in the biopharmaceutical industry, starting as a sales representative and ultimately rising to become CEO at Ranbaxy South Africa's Sonke Pharmaceuticals. During his career he led the team that marketed and sold the first South African over-the-counter product in the Middle East and Africa and also negotiated and sold the first voluntarily licensed antiretroviral products into Sub-Saharan Africa. Mr. Areff served as Aspen Pharmacare's sales and marketing country manager for Nigeria, Uganda, and Libya for the launch of Gilead Sciences' Viread and Truvada. He also served as senior executive of new business development for Cipla Medpro and led commercial due diligence of the sale of Cipla Medpro to Enaleni Pharma. He has a diploma in journalism from Damelin College.

Andrew de Pão
Chief Business Officer
Mr. de Pão served as Head of Marketing for the Prescription Division at Cipla South Africa, as well as the commercial lead for Cipla South Africa Biosimilars Task Team. While there, he spearheaded the development and implementation of peri-, pre-, and post-launch clinical, marketing and communication campaigns across all prescription and OTX disease categories. Prior to joining Cipla South Africa, Mr. de Pão held a Healthcare Communications Consultant and Directors position at Publicis Global Healthcare Communications Group in the United Kingdom, where his team was involved in development of Global Brand Communication Strategies for various multinational pharmaceutical companies and provided corporate brand positioning and development and execution of digital and social media programs. He holds a Bachelor's in Physiology and Biochemistry and a Master's in Physiology from the University of Stellenbosch, South Africa.

Nahum Johnson
Director State and Institutional Business
Mr. Johnson has 20 years of experience in the biopharmaceutical industry. He most recently served as Pharma Unit Manager-State Institutional and Government at Cipla Medpro. Prior to that, he served as Key Account Manager-Public Sector for Adcock Ingram. He has a Bachelor's in Biochemistry from the University of the Western Cape, a postgraduate degree in Management Development Practice from the Department of Management Sciences, Business Graduate School UNISA; and is currently completing a Master's in Information Systems Knowledge Management.

About Serenus Biotherapeutics
Serenus Biotherapeutics is a privately held specialty biopharmaceutical company that specializes in late-stage drug development, in-licensing, registering, and commercializing therapies approved in the United States, Europe, and Japan to address unmet medical needs with high regional prevalence in the Sub-Saharan African market. For more information, please visit www.serenusbio.com

Contact:
Daniel Levine
Levine Media Group
(510) 280-5405
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
SYS-CON Events announced today Isomorphic Software, the global leader in high-end, web-based business applications, will exhibit at SYS-CON's DevOps Summit 2015 New York, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Isomorphic Software is the global leader in high-end, web-based business applications. We develop, market, and support the SmartClient & Smart GWT HTML5/Ajax platform, combining the productivity and performance of traditional desktop software ...
SYS-CON Media announced today that Sematext launched a popular blog feed on DevOps Journal with over 6,000 story reads over the weekend. DevOps Journal is focused on this critical enterprise IT topic in the world of cloud computing. DevOps Journal brings valuable information to DevOps professionals who are transforming the way enterprise IT is done. Sematext is a globally distributed organization that builds innovative Cloud and On Premises solutions for performance monitoring, alerting an...
SYS-CON Media announced today that Skytap blog on "DevOps Journal" exceeded 84,000 story reads. DevOps Journal is focused on this critical enterprise IT topic in the world of cloud computing. DevOps Journal brings valuable information to DevOps professionals who are transforming the way enterprise IT is done. Noel Wurst is the managing content editor at Skytap. Skytap provides SaaS-based dev/test environments to the enterprise. Skytap solution removes the inefficiencies and constraints that comp...
ScriptRock makes GuardRail, a DevOps-ready platform for configuration monitoring. Realizing we were spending way too much time digging up, cataloguing, and tracking machine configurations, we began writing our own scripts and tools to handle what is normally an enormous chore. Then we took the concept a step further, giving it a beautiful interface and making it simple enough for our bosses to understand. We named it GuardRail after its function - to allow businesses to move fast and stay sa...
SYS-CON Events announced today that Cloudian, Inc., the leading provider of hybrid cloud storage solutions, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Cloudian, Inc., is a Foster City, California - based software company specializing in cloud storage software. The main product is Cloudian, an Amazon S3-compliant cloud object storage platform, the bedrock of cloud computing systems, that enables c...
Leysin American School is an exclusive, private boarding school located in Leysin, Switzerland. Leysin selected an OpenStack-powered, private cloud as a service to manage multiple applications and provide development environments for students across the institution. Seeking to meet rigid data sovereignty and data integrity requirements while offering flexible, on-demand cloud resources to users, Leysin identified OpenStack as the clear choice to round out the school's cloud strategy. Additional...
SYS-CON Events announced today that Windstream, a leading provider of advanced network and cloud communications, has been named “Silver Sponsor” of SYS-CON's 16th International Cloud Expo®, which will take place on June 9–11, 2015, at the Javits Center in New York, NY. Windstream (Nasdaq: WIN), a FORTUNE 500 and S&P 500 company, is a leading provider of advanced network communications, including cloud computing and managed services, to businesses nationwide. The company also offers broadband, p...
The BPM world is going through some evolution or changes where traditional business process management solutions really have nowhere to go in terms of development of the road map. In this demo at 15th Cloud Expo, Kyle Hansen, Director of Professional Services at AgilePoint, shows AgilePoint’s unique approach to dealing with this market circumstance by developing a rapid application composition or development framework.
In high-production environments where release cycles are measured in hours or minutes — not days or weeks — there's little room for mistakes and no room for confusion. Everyone has to understand what's happening, in real time, and have the means to do whatever is necessary to keep applications up and running optimally. DevOps is a high-stakes world, but done well, it delivers the agility and performance to significantly impact business competitiveness.
"Our premise is Docker is not enough. That's not a bad thing - we actually love Docker. At ActiveState all our products are based on open source technology and Docker is an up-and-coming piece of open source technology," explained Bart Copeland, President & CEO of ActiveState Software, in this SYS-CON.tv interview at DevOps Summit at Cloud Expo®, held Nov 4-6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
The Internet of Things is not new. Historically, smart businesses have used its basic concept of leveraging data to drive better decision making and have capitalized on those insights to realize additional revenue opportunities. So, what has changed to make the Internet of Things one of the hottest topics in tech? In his session at @ThingsExpo, Chris Gray, Director, Embedded and Internet of Things, discussed the underlying factors that are driving the economics of intelligent systems. Discover ...
"BSQUARE is in the business of selling software solutions for smart connected devices. It's obvious that IoT has moved from being a technology to being a fundamental part of business, and in the last 18 months people have said let's figure out how to do it and let's put some focus on it, " explained Dave Wagstaff, VP & Chief Architect, at BSQUARE Corporation, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4-6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
The major cloud platforms defy a simple, side-by-side analysis. Each of the major IaaS public-cloud platforms offers their own unique strengths and functionality. Options for on-site private cloud are diverse as well, and must be designed and deployed while taking existing legacy architecture and infrastructure into account. Then the reality is that most enterprises are embarking on a hybrid cloud strategy and programs. In this Power Panel at 15th Cloud Expo (http://www.CloudComputingExpo.com...
Verizon Enterprise Solutions is simplifying the cloud-purchasing experience for its clients, with the launch of Verizon Cloud Marketplace, a key foundational component of the company's robust ecosystem of enterprise-class technologies. The online storefront will initially feature pre-built cloud-based services from AppDynamics, Hitachi Data Systems, Juniper Networks, PfSense and Tervela. Available globally to enterprises using Verizon Cloud, Verizon Cloud Marketplace provides a one-stop shop fo...
SYS-CON Events announced today that IDenticard will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. IDenticard™ is the security division of Brady Corp (NYSE: BRC), a $1.5 billion manufacturer of identification products. We have small-company values with the strength and stability of a major corporation. IDenticard offers local sales, support and service to our customers across the United States and Canada...